Physical Activity as an Effect Modifier of the Association Between Obesity and Venous Thromboembolism: A Danish Population-Based Cohort Study.

PURPOSE: Obesity is an established risk factor for venous thromboembolism (VTE), while studies on physical inactivity and VTE risk show conflicting results. We examined whether physical activity modified the association between obesity and VTE. PATIENTS AND METHODS: We conducted a population-based cohort study by combining data on outcome diagnoses, comorbidities and medication from nationwide registries with self-reported lifestyle data from an extensive Danish lifestyle questionnaire (2001-2015). We computed incidence rates (IRs) and hazard ratios (HRs) of VTE for categories of body mass index (BMI), among the total study population (n=57,523) and for physically active (n=25,387) and inactive individuals (n=30,902) separately.
RESULTS: Obesity (BMI ≥30 kg/m2) was as expected associated with increased VTE risk compared with normal weight (HR 1.62, 95% confidence interval (CI): 1.26-2.09). Independent of BMI category, the rate of VTE was higher for inactive than active individuals. Thus, among obese individuals, the IR per 1000 person-years was 2.03 (95% CI: 1.60-2.57) for inactive and 1.44 (95% CI: 0.97-2.15) for active individuals. In contrast, the HR for VTE comparing obese with normal weight individuals were higher for active (HR 2.19, 95% CI: 1.35-3.58) than inactive individuals (HR 1.36, 95% CI: 1.00-1.84).
CONCLUSION: Physical activity acts as an effect measure modifier of the association between obesity and VTE. Thus, physical activity reduced the absolute rate of VTE among obese individuals but increased the relative rate of VTE among obese compared with normal weight individuals.

Introduction

Venous thromboembolism (VTE) includes deep venous thrombosis and pulmonary embolism. VTE has a reported incidence rate (IR) per 1000 person-years (PY) of 1.5 in individuals aged 15 and older, rising sharply with age.1 VTE is a potentially lethal condition2 and is a leading cause of preventable in-hospital deaths.3 Conditions leading to a pro-thrombotic state, such as pregnancy, surgery, trauma, cancer, and immobilization, are all established as transient risk factors for VTE.1

A growing body of research has pointed to obesity as a risk factor for VTE.4–11 In 2008, a meta-analysis pooling studies of high quality in which body mass index (BMI) was adequately measured found an odds ratio of 1.84 (95% confidence interval (CI): 1.55–2.18) for VTE among obese individuals.12 Studies investigating the association between physical activity and VTE have reported conflicting results.6–11,13–17 Thus, some studies have found that physical activity either reduce10,11,15–17 or, under some conditions, increase6,13–15 the risk of VTE, while others found no association.7–9,13,14 While some studies have investigated whether BMI modifies the association between physical activity and VTE,13,15 to our knowledge, no previous study has assessed whether physical activity modifies the obesity-associated risk on VTE.

We hypothesized that physical activity reduced the rate for VTE among obese individuals, making physical activity an effect measure modifier of the association between obesity and VTE. We therefore identified responders to an extensive lifestyle questionnaire and conducted a cohort study to assess the association between BMI and VTE among physically active and inactive individuals.

Patients and Methods

Setting

We conducted this cohort study among residents in one of Denmark’s five regions, the Central Denmark Region, which has a population of approximately 1.3 million individuals.18 The Danish National Health Service provides universal tax-supported health care which guarantees free and unfettered access to general practitioners and hospitals, and partial reimbursement for prescribed medications.19

Accurate and unambiguous individual-level linkage of all Danish registries is possible using the unique Civil Personal Register (CPR) number assigned to all residents at birth or upon immigration.20 The CPR number is issued by the Danish Civil Registration System which is updated daily and contains vital statistics of members of the Danish population – including date of birth, change of address, date of emigration, and exact date of death – dating back to 1968.20

Study Cohort

The questionnaire-based public health survey “How Are You?” has been conducted five times since 2001 by The Population Health Surveys unit, Central Denmark Region.21 Our study population included all individuals who answered the questionnaire in 2001, 2006, and 2010. Questionnaires were distributed by mail to a random sample of inhabitants of the Central Denmark Region aged 25–79, and from 2010: aged 16 and older, with at least one parent born in Denmark. Study participation was voluntary, and participants provided self-reported answers to a detailed questionnaire regarding lifestyle factors containing approximately 400 questions. Response rates for the different questionnaires varied between 76% and 65%.22 A total of 57,523 individuals were eligible for inclusion in the study population.

Exposure Variables

Information regarding our two exposure variables, BMI and physical activity, was extracted from the “How Are You?” survey. BMI was calculated as weight in kilograms divided by height in meters squared and grouped into four categories, as defined by the World Health Organization: underweight (BMI<18.5), normal weight (18.5≤BMI<25), overweight (25≤BMI<30), and obese (BMI≥30).23 Physical activity was dichotomized as “active” and “inactive”. Because of minor differences in the wording of the different questionnaires, some discrepancies occurred among the sub-cohorts. All physically active questionnaire responders stated that they conducted sport or other physical activity in their spare time on a regular basis. In addition to this, physically active individuals in the 2001 sub-cohort stated that their activities exceeded 2 hours per week, whereas physically active individuals in the 2006 and 2010 sub-cohort stated that they spent at least 2 days per week with more than 30 minutes of moderate to strenuous physical activity during work or spare time.

Outcome Variables

We used the Danish National Patient Registry (DNPR) to identify all individuals with a first-time primary or secondary diagnosis of VTE (defined as deep venous thrombosis or pulmonary embolism).24 The DNPR records information on patients discharged from all Danish non-psychiatric hospitals since 1 January 1977 and from all emergency room and outpatient specialty clinic visits since 1995.24 Each hospital discharge or outpatient visit is recorded in the registry with one primary diagnosis and one or more secondary diagnoses classified according to the International Classification of Diseases, 8th revision (ICD-8) until the end of 1993 and the 10th revision (ICD-10) thereafter.24

We further subdivided VTE diagnoses into provoked and unprovoked events.6 A VTE event was defined as provoked if the patient had a history of malignancy any time prior to or within 90 days after the diagnosis of VTE or a recorded discharge diagnosis of fracture, trauma, surgery, or pregnancy within 90 days before the VTE diagnosis. Conditions defining provoked VTE were recorded in the DNPR. Remaining cases were classified as unprovoked.

Covariates

The Danish National Health Service Prescription Database (DNHSPD) was used to identify the use of different classes of medications among study participants.25 This database encompasses the reimbursement records of all reimbursable drugs sold in community pharmacies and hospital-based outpatient pharmacies in Denmark since 2004. Stored in the database is information regarding the dispensed drug (name, form, strength, and pack size), patient, prescriber, and pharmacy.25 Drug use was defined as a registered redemption of a reimbursable drug within 90 days before start of follow-up. We collected data on statins, vitamin K antagonists, and low-dose aspirin. We did not record use of Non-vitamin K antagonist oral anticoagulants (NOACs), as these drugs were not available in Denmark at start of follow-up for the different sub-cohorts (2001–2010).

We used the Charlson comorbidity index (CCI) to assess each individual’s burden of comorbidity.26 The CCI assigns between one to six points to a range of diseases depending on their severity and anticipated 1-year mortality.26 Diagnoses included in the CCI were extracted from the DNPR.27 For all 19 comorbidities in the index, we computed the cumulative score for each individual study participant and defined three categories of comorbidity based on scores of 0 (low), 1–2 (moderate), and ≥3 (severe).28

Diagnoses of hypertension, atrial fibrillation/flutter, and diabetes were extracted from the DNPR, combined with prevalence of either hypertension or diabetes stated in the “How Are You?” questionnaire. We also used the redemption of anti-diabetic drugs through the DNHSPD to identify diabetic patients.25

Potential confounding lifestyle variables were extracted from the “How Are You?” questionnaire. Smoking status was categorized into three categories: never smokers, former smokers, and current smokers. Level of education was grouped into three categories: 1) ≤10 years of primary education, 2) high school, vocational training or equivalent, or short higher education, and finally 3) higher education of medium or long duration.

Statistical Analysis

All individuals were followed from the date of return of the questionnaire in 2001, 2006, or 2010, depending on the sub-cohort, and until the date of outcome, death, emigration, or 1 January 2015, whichever came first. We censored all analysis time at the date of the first VTE event, regardless of whether the event was provoked or unprovoked. We excluded all individuals with a recorded diagnosis of VTE before start of follow-up from the study population (n=534). For individuals with missing information regarding one or more lifestyle factors in the “How Are You?” survey, we imputed the missing values using the multiple imputation by chained equations (MICE) method.29 Among the individuals (n=1690) who was sent more than one questionnaire, we used the date and lifestyle factors reported in the first answered questionnaire as baseline, and all later questionnaire answers were disregarded. To assess physical activity as an effect measure modifier of the association between obesity and VTE, we made two sub-cohorts of physically active and inactive individuals. Individuals with missing information regarding physical activity (n=1234, including 26 with VTE events) were excluded from this sub-analysis.

We calculated IRs as numbers of outcomes per 1000 person-years for BMI and physical activity groups. We computed crude and adjusted hazard ratios (HRs) for all BMI groups using normal weight individuals as reference for all outcome events using Cox proportional-hazards regression. Carefully taking into consideration the relatively few number of outcomes, we chose to include only relevant confounding variables in our multivariate statistical model using the “change in estimate”-method.30 Although diabetes may be a risk factor for VTE, we chose not to adjust for this condition, as diabetes may be an intermediary step on the causal pathway between obesity and VTE, and thus not represent a confounding covariate. The proportional hazard assumption was assessed graphically for all analyses by plotting log(-log(survival function)) against time, and it was found to be valid. All statistical analyses were conducted using Stata software version 12.1.

Results

Descriptive Data

The demographical data for the total study population (n=57,523) according to BMI group (Table 1) showed that obese individuals had a higher proportion of physical inactivity compared with other BMI groups. Obese also had a higher burden of comorbidity, both Charlson Comorbidity Index score, individual comorbidities, and use of cardiovascular drugs.

Table 1

Study Population Characteristics According to Body Mass Index Category*

	Total Study Population	Underweight	Normal Weight	Overweight	Obese
Total	57,523 (100)	1120 (100)	27,607 (100)	19,695 (100)	7775 (100)
Female sex	30,494 (53.1)	908 (81.1)	16,718 (60.6)	8024 (40.7)	3960 (50.9)
Age
<40	16,355 (28.4)	547 (48.8)	9317 (33.8)	4405 (22.4)	1832 (23.6)
40–49	11,739 (20.4)	127 (11.3)	5708 (20.7)	4084 (20.7)	1656 (21.3)
50–59	11,888 (20.7)	146 (13.0)	5328 (19.3)	4466 (22.7)	1766 (22.7)
60–69	10,632 (18.5)	142 (12.7)	4361 (15.8)	4242 (21.5)	1658 (21.3)
≥70	6909 (12.0)	158 (14.1)	2893 (19.5)	2498 (12.7)	863 (11.1)
Cohort
2001	3960 (6.9)	80 (7.1)	2064 (7.5)	1292 (6.6)	443 (5.7)
2006	21,291 (37.0)	314 (28.0)	10,105 (36.6)	7556 (38.4)	2853 (36.7)
2010	32,272 (56.1)	726 (64,9)	15,438 (56.0)	10,847 (55.1)	4479 (57.6)
Smoking status
Never	27,084 (47.1)	566 (50.5)	13,656 (49.5)	8745 (44.4)	3586 (46.1)
Former	15,783 (27.4)	166 (14.8)	6653 (24.1)	6192 (31.4)	2491 (32.0)
Current	13,002 (22.6)	362 (32.3)	6689 (24.2)	4221 (21.4)	1474 (19.0)
Missing information	1654 (2.9)	26 (2.3)	609 (2.2)	537 (2.7)	224 (2.9)
Physical activity
Active	25,387 (44.1)	432 (38.6)	13,652 (49.5)	8416 (42.7)	2566 (33.0)
Inactive	30,902 (53.7)	650 (58.0)	13,525 (49.0)	10,952 (55.6)	5068 (65.2)
Missing information	1234 (2.2)	38 (3.4)	430 (1.6)	327 (1.7)	141 (1.8)
Level of education
Up to10 years	15,489 (26.9)	427 (38.1)	6433 (23.3)	5540 (28.1)	2579 (33.2)
High school or equivalent	26,231 (45.6)	417 (37.2)	12,586 (45.6)	9212 (46.8)	3645 (46.9)
Medium to long	13,652 (23.7)	220 (19.6)	7714 (27.9)	4303 (21.9)	1261 (16.2)
Missing information	2151 (3.7)	56 (5.0)	874 (3.2)	640 (3.3)	290 (3.7)
Comorbidity
Low	47,127 (81.9)	861 (76.9)	23,318 (84.5)	16,089 (81.7)	5944 (76.5)
Moderate	8669 (15.1)	197 (17.6)	3627 (13.1)	3016 (15.3)	1511 (19.4)
High	1727 (3.0)	62 (5.5)	662 (2.4)	590 (3.0)	320 (4.1)
Diabetes	2935 (5.1)	30 (2.7)	787 (2.9)	1051 (5.3)	939 (12.1)
Hypertension	12,787 (22.2)	123 (11.0)	4175 (15.1)	5096 (25.9)	2998 (38.6)
Atrial fibrillation/flutter	1222 (2.1)	23 (2.1)	418 (1.5)	467 (2.4)	251 (3.2)
Statins	4891 (8.5)	51 (4.6)	1528 (5.5)	2063 (10.5)	1085 (14.0)
Vitamin K antagonists	694 (1.2)	8 (0.7)	235 (0.9)	252 (1.3)	166 (2.1)
Low-dose aspirin	3814 (6.6)	54 (4.8)	1210 (4.4)	1547 (7.9)	809 (10.4)

Notes: *A total of 1326 individuals had missing data on body mass index.

When stratifying the study population (n=57,523) on the physically active (n=25,387) and inactive (n=30,902) individuals (Table 2), we found that, independent of BMI category, inactive individuals had a higher proportion of current smokers, a lower level of education, and a higher burden of comorbidity and drug use than the physically active individuals.

Table 2

Study Population Characteristics According to Body Mass Index Category and Physical Activity

	Total Study Population		Underweight		Normal Weight		Overweight		Obese
	Active	Inactive	Active	Inactive	Active	Inactive	Active	Inactive	Active	Inactive
Total	25,387 (100)	30,902 (100)	432 (100)	650 (100)	13,652 (100)	13,525 (100)	8416 (100)	10,952 (100)	2566 (100)	5068 (100)
Female sex	14,096 (55.5)	15,657 (50.7)	355 (82.2)	522 (80.3)	8591 (62.9)	7837 (57.9)	3532 (42.0)	4333 (39.6)	1390 (54.2)	2488 (49.1)
Age
<40	8236 (32.4)	7934 (25.7)	255 (59.0)	279 (42.9)	5013 (36.7)	4232 (31.3)	2168 (25.8)	2200 (20.1)	710 (27.7)	1104 (21.8)
40–49	5567 (21.9)	6068 (19.6)	49 (11.3)	77 (11.9)	3023 (22.1)	2641 (19.5)	1848 (22.0)	2209 (20.2)	597 (23.3)	1050 (20,7)
50–59	4979 (19.6)	6741 (21.8)	56 (13.0)	89 (13.7)	2496 (18.3)	2763 (20.4)	1822 (21.7)	2592 (23.7)	555 (21.6)	1191 (23.5)
60–69	4396 (17.3)	5959 (19.3)	44 (10.2)	91 (14.0)	2059 (15.1)	2211 (16.4)	1731 (20.6)	2427 (22.2)	514 (20.0)	1104 (21.8)
≥70	2209 (8.7)	4200 (15.6)	28 (6.5)	114 (17.5)	1061 (7.8)	1678 (12.4)	847 (10.1)	1524 (13.9)	190 (7.4)	619 (12.2)
Cohort
2001	1695 (6.7)	2177 (7.0)	29 (6.7)	46 (7.1)	980 (7.2)	1054 (7.8)	534 (6.4)	736 (6.7)	137 (5.3)	294 (5.8)
2006	8274 (32.6)	12,561 (40.7)	86 (19.9)	217 (33.4)	4358 (31.9)	5583 (41.3)	2864 (34.0)	4547 (41.5)	842 (32.8)	1954 (38.6)
2010	15,418 (60.8)	16,164 (52.3)	317 (73.4)	387 (59.5)	8314 (60,9)	6888 (50.9)	5018 (59,6)	5669 (51,7)	1587 (61,9)	2820 (55,7)
Smoking status
Never smoker	13,739 (54.1)	12,974 (42.0)	277 (64.1)	274 (42.2)	7786 (57.0)	5720 (42.3)	4200 (49.9)	4441 (40.6)	1318 (51.4)	2221 (43.8)
Former smoker	7099 (28.0)	8398 (27.2)	56 (13.0)	105 (16.2)	3397 (24.9)	3145 (23.3)	2717 (32.3)	3379 (30.9)	843 (32.9)	1609 (31.8)
Current smoker	4011 (15.8)	8736 (28.3)	93 (21.5)	256 (39.4)	2213 (16.2)	4362 (32.3)	1309 (15.6)	2843 (26.0)	342 (13.3)	1100 (21.7)
Missing information	538 (2.1)	794 (2.6)	6 (1.4)	15 (2.3)	256 (1.9)	298 (2.2)	190 (2.3)	289 (2.6)	63 (2.5)	138 (2.7)
Level of education
Up to10 years	5230 (20.6)	9748 (31.5)	140 (32.4)	268 (41.2)	2464 (18.1)	3776 (27.9)	1870 (22.2)	3514 (32.1)	650 (25.3)	1858 (36.7)
High school or equivalent	11,989 (47.2)	13,942 (45.1)	164 (38.0)	241 (37.1)	6302 (46.2)	6151 (45.5)	4111 (48.9)	5005 (45.7)	1288 (50.2)	2319 (45.8)
Medium to long	7421 (29.2)	6107 (19.8)	114 (26.4)	103 (15.9)	4498 (33.0)	3151 (23.3)	2188 (26.0)	2077 (19.0)	552 (21.5)	699 (13.8)
Missing information	747 (2.9)	1105 (3.6)	14 (3.2)	38 (5.9)	388 (2.8)	447 (3.3)	247 (2.9)	356 (3.3)	76 (3.0)	192 (3.8)
Comorbidity
Low	21,788 (85.8)	24,500 (79.3)	381 (88.2)	458 (70.5)	11,916 (87.3)	11,071 (81.9)	7157 (85.0)	8704 (79,5)	2067 (80.6)	3793 (74.8)
Moderate	3143 (12.4)	5215 (16.9)	46 (10.7)	137 (21.1)	1521 (11.1)	2025 (15.0)	1092 (13.0)	1840 (16.8)	427 (16.6)	1039 (20.5)
High	466 (1.8)	1187 (3.8)	5 (1.2)	55 (8.5)	215 (1.6)	429 (3.2)	167 (2.0)	408 (3.7)	72 (2.8)	236 (4.7)
Diabetes	928 (3.7)	1899 (6.2)	8 (1.9)	21 (3.2)	299 (2.2)	468 (3.5)	337 (4.0)	682 (6.2)	270 (10.5)	644 (12.7)
Hypertension	4694 (18.5)	7710 (25.0)	23 (5.3)	93 (14.3)	1764 (12.9)	2302 (17.0)	1952 (23.2)	3030 (27.7)	885 (34.5)	2048 (40.4)
Atrial fibrillation/flutter	362 (1.4)	792 (2.6)	1 (0.2)	19 (2.9)	147 (1.1)	256 (1.9)	155 (1.8)	300 (2.7)	54 (2.1)	186 (3.7)
Statins	1782 (7.0)	2937 (9.5)	12 (2.8)	34 (5.2)	652 (4.8)	829 (6.1)	778 (9.2)	1229 (11.2)	315 (12.3)	747 (14.7)
Vitamin K antagonists	189 (0.7)	464 (1.5)	2 (0.5)	6 (0.9)	83 (0.6)	140 (1.0)	70 (0.8)	172 (1.6)	32 (1.3)	127 (2.5)
Low-dose aspirin	1148 (4.5)	2483 (8.0)	8 (1.9)	42 (6.5)	398 (2.9)	773 (5.7)	505 (6.0)	991 (9.0)	213 (8.3)	566 (11.2)

Effect Measures

A total of 534 VTE events were recorded during the follow-up time, 257 of which were provoked and 277 of which were unprovoked (Table 3). A total of 385,814 person-years of follow-up were recorded. The adjusted HR for VTE using normal weight individuals as reference were 0.96 (95% CI: 0.42–2.15) for underweight, 1.34 (95% CI: 1.09–1.64) for overweight, and 1.62 (95% CI: 1.26–2.09) for obese individuals. For overweight individuals, the HR did not differ between provoked and unprovoked VTE. For obese individuals, the risk of unprovoked VTE was 1.81 (95% CI: 1.27–2.58) and 1.43 (95% CI: 0.98–2.08) for provoked VTE.

Table 3

Association Between Body Mass Index and Venous Thromboembolism

	Person-Years	Outcomes	IR per 1000 PY (95% CI)	Crude HR (95% CI)	Adjusted* HR (95% CI)
VTE overall†
Normal weight	187,052	187	1.00 (0.87–1.15)	1 (reference)	1 (reference)
Underweight	6773	6	0.89 (0.40–1.97)	0.95 (0.43–2.13)	0.96 (0.42–2.15)
Overweight	132,725	213	1.60 (1.40–1.84)	1.64 (1.35–1.99)	1.34 (1.09–1.64)
Obesity	51,104	97	1.90 (1.56–2.32)	1.94 (1.52–2.47)	1.62 (1.26–2.09)
VTE provoked
Normal weight	187,052	91	0.49 (0.40–0.60)	1 (reference)	1 (reference)
Underweight	6773	5	0.74 (0.31–1.78)	1.56 (0.64–3.82)	1.41 (0.57–3.50)
Overweight	132,725	103	0.78 (0.64–0.94)	1.63 (1.23–2.17)	1.34 (1.00–1.78)
Obesity	51,104	43	0.84 (0.62–1.13)	1.76 (1.23–2.53)	1.43 (0.98–2.08)
VTE unprovoked
Normal weight	187,052	96	0.51 (0.42–0.63)	1 (reference)	1 (reference)
Underweight	6773	1	0.15 (0.02–1.05)	0.35 (0.05–2.46)	0.39 (0.56–2.73)
Overweight	132,725	110	0.83 (0.69–1.00)	1.64 (1.25–2.15)	1.34 (1.01–1.77)
Obesity	51,104	54	1.06 (0.81–1.38)	2.11 (1.50–2.95)	1.81 (1.27–2.58)

Notes: *Adjusted for the following sets of covariates: age, sex, smoking status, physical activity, level of education, hypertension, atrial fibrillation/flutter, Charlson Comorbidity Index score, statins, vitamin K antagonists, low-dose aspirin. 31 VTE events occurred among individuals with missing information on body mass index, and are therefore not shown.

When stratifying by physical activity, we observed that 168 VTE events occurred among active individuals and 340 events among inactive individuals. Inactive individuals had a consistent higher IR compared with active individuals overall () and within the same BMI group (Table 4). Comparing active vs inactive individuals’ incidence rates per 1000 person-years for VTE yielded the following results: 0.63 (95% CI: 0.48–0.81) vs 1.32 (95% CI: 1.11–1.57) for normal weight, 1.49 (95% CI: 1.20–1.84) vs 1.70 (95% CI: 1.43–2.02) for overweight, and 1.44 (95% CI: 0.97–2.15) vs 2.03 (95% CI: 1.60–2.57) for obesity.

Table 4

Association Between Body Mass Index and Venous Thromboembolism Among Physically Active and Inactive Individuals

	Person-Years	Outcomes	IR per 1000 PY (95% CI)	Crude HR (95% CI)	Adjusted* HR (95% CI)
VTE overall
Physically active
Normal weight	91,067	57	0.63 (0.48–0-81)	1 (reference)	1 (reference)
Underweight	2608	0	–	–	–
Overweight	55,855	83	1.49 (1.20–1.84)	2.39 (1.71–3.35)	2.10 (1.48–2.97)
Obesity	16,650	24	1.44 (0.97–2.15)	2.31 (1.44–3.72)	2.19 (1.35–3.58)
Physically inactive
Normal weight	93,233	123	1.32 (1.11–1.57)	1 (reference)	1 (reference)
Underweight	3964	5	1.26 (0.52–3.03)	0.97 (0.40–2.35)	1.02 (0.42–2.50)
Overweight	74,640	127	1.70 (1.43–2.02)	1.33 (1.04–1.70)	1.10 (0.85–1.41)
Obesity	33,540	68	2.03 (1.60–2.57)	1.58 (1.18–2.12)	1.36 (1.00–1.84)
VTE provoked
Physically active
Normal weight	91,067	26	0.29 (0.19–0.42)	1 (reference)	1 (reference)
Underweight	2608	0	–	–	–
Overweight	55,855	31	0.56 (0.39–0.79)	1.97 (1.17–3.32)	1.78 (1.04–3.04)
Obesity	16,650	13	0.78 (0.45–1.34)	2.70 (1.39–5.26)	2.35 (1.17–4.71)
Physically inactive
Normal weight	93,233	62	0.67 (0.52–0.85)	1 (reference)	1 (reference)
Underweight	3964	4	1.01 (0.38–2.69)	1.50 (0.55–4.12)	1.44 (0.52–3.98)
Overweight	74,640	71	0.95 (0.75–1.20)	1.47 (1.05–2.06)	1.25 (0.88–1.76)
Obesity	33,540	28	0.83 (0.58–1.21)	1.30 (0.83–2.04)	1.14 (0.72–1.81)
VTE unprovoked
Physically active
Normal weight	91,067	31	0.34 (0.24–0.48)	1 (reference)	1 (reference)
Underweight	2608	0	–	–	–
Overweight	55,855	52	0.93 (0.71–1.22)	2.75 (1.77–4.30)	2.37 (1.50–3.76)
Obesity	16,650	11	0.66 (0.37–1.19)	1.98 (0.99–3.94)	1.96 (0.97–3.96)
Physically inactive
Normal weight	93,233	61	0.65 (0.51–0.84)	1 (reference)	1 (reference)
Underweight	3964	1	0.25 (0.04–1.79)	0.40 (0.05–2.88)	0.47 (0.06–3.41)
Overweight	74,640	56	0.75 (0.58–0.97)	1.17 (0.82–1.69)	0.95 (0.65–1.38)
Obesity	33,540	40	1.19 (0.87–1.63)	1.87 (1.25–2.79)	1.57 (1.04–2.38)

Notes: *Adjusted for the following sets of covariates: age, sex, smoking status, level of education, hypertension, atrial fibrillation/flutter, Charlson Comorbidity Index score, statins, vitamin K antagonists, low-dose aspirin.

The adjusted HR for VTE among overweight individuals compared with normal weight individuals were 2.10 (95% CI: 1.48–2.97) for active individuals and 1.10 (95% CI: 0.85–1.41) for inactive individuals. Among overweight individuals, active individuals had higher HRs of both provoked and unprovoked VTE compared with inactive individuals, the most pronounced difference being for unprovoked VTE. Obese individuals had an adjusted HR compared with normal weight individuals of 2.19 (95% CI: 1.35–3.58) for active and 1.36 (95% CI: 1.00–1.84) for inactive individuals. Among obese individuals, active individuals also had higher HRs of both provoked and unprovoked VTE, but here, the highest HR and broadest difference were found for provoked VTE.

Discussion

We found that obesity and physical inactivity were both risk factors of VTE. Importantly, physical inactivity increased the BMI-associated risk of VTE. Physical inactivity thus acted as an effect measure modifier. Obesity increased the rate of VTE compared with normal weight individuals relatively more in physical active individuals, likely due to the lower baseline risk of VTE among physical active individuals.

Comparison with Other Studies

Our results are in accordance with previous studies which have identified obesity as a risk factor for VTE.4–11 Studies investigating the association between physical activity and risk of VTE have reached different conclusions.6–11,13–17 Some studies have reported no association between physical activity as a whole and overall VTE,7–9,13,14 while others have found a reduction in VTE risk among physically active individuals.10,11,15–17 Furthermore, some studies have found an increased risk for VTE, especially provoked VTE among practitioners of strenuous exercise.6,13–15 This last finding is interesting, as it points to exercise having an opposite effect on arterial and venous thrombotic diseases.6

Two studies should be emphasized for their interesting conclusions in assessing the interplay between obesity and physical activity on VTE-risk. Borch et al13 conducted a cohort study among the general population of one region of Norway. Regular physical activity of both moderate and high intensity had no statistically significant effect on risk of overall VTE. High-intensity exercise was associated with an elevated risk of provoked VTE compared with inactive individuals, and moderate physical activity was associated with a decreased risk of VTE among subjects under 60 years of age. Borch et al found similar risk estimates for each BMI group; however, normal weight individuals who conducted moderate physical activity had a lower risk of VTE compared with inactive normal weight individuals, and obese individuals who conducted strenuous activity had a higher risk of VTE compared with obese inactive individuals.13 Armstrong et al15 conducted a cohort study as part of the Million Women Study, containing 1.1 million British women without previous vascular disease. Individuals who conducted moderate physical activity had a significant lower risk of VTE, as well as coronary heart disease and cerebrovascular events, compared with inactive individuals. Strenuous activity increased the risk of all three conditions. Armstrong et al found no strong evidence of heterogeneity between categories of BMI.15

Pathophysiological Explanations

Virchow’s triad states that the three main causes of thrombosis are venous stasis, endothelial injury, and hypercoagulability. Obesity has been linked with all these causes. Body fat may raise the intra-abdominal pressure and in turn limit venous return from the lower extremities.31 Perivascular adipose tissue in obese individuals is known to promote endothelial oxidative stress and a reduced bioavailability of nitric oxide.32 Furthermore, obesity has been showed to be correlated with elevated levels of several coagulation factors.31,33

Through several mechanisms, physical activity may counteract the adverse effects of obesity on thrombosis. Body movement activates the skeletal muscle pump, which in turn promotes venous return.34,35 Physical activity has been shown to reduce levels of C-reactive protein, which is a general marker of inflammation,36 as well as having beneficial effects on endothelial function, plasma viscosity, and platelet aggregation.37 However, all of the vascular beneficial effects of physical activity may be reverted due to the risk of exercise-induced injury, which may lead to both prolonged immobilization as well as tissue damage.38,39 The pathophysiological relationship between obesity, physical activity, and thrombosis is therefore complex to assess.

Strengths and Limitations

Some issues should be considered when interpreting our results. The free access to health care provided by the Danish Health System and the computerized manner in which discharge diagnoses are recorded minimized referral and diagnostic biases of the diagnosis of VTE. The positive predictive value of a VTE diagnosis in the DNPR has been reported as 88% for first-time events.40 Prevalence of diabetes and hypertension was not only determined by discharge diagnoses but also by reported comorbidity in the lifestyle questionnaire and, with regards to diabetes, redemption of antidiabetic drugs.

We cannot exclude unmeasured confounding. In general, responders to health questionnaires tend to be healthier than individuals who decline to participate. However, our study population had comparable proportions of both diabetic41 and hypertensive42 patients as well as BMI groups43 to that of the general Danish population. Although lifestyle factors such as obesity and smoking status tend to be underreported in questionnaires,44,45 because the information in the questionnaire was collected at the start of follow-up, we find it unlikely that the manner in which the questionnaire was answered should be associated with whether or not the individual experienced a VTE event. Still, the fact that lifestyle factors, among these our exposure variables BMI and physical activity, were based on self-reported data rather than direct measurements, is a limitation.

We were unable to record individual changes in categories of BMI, physical activity or confounding variables after start of follow-up. A recent study on lifestyle factors and risk of myocardial infarction and VTE found similar risk estimates when recoding lifestyle data once versus adjusting risk estimates for changes in lifestyle through several re-assessments of lifestyle factors.46

There is a potential risk of residual confounding, as physical activity was only dichotomized as active/inactive, in contrast to previous studies, which have been able to further quantify the amount of physical activity. Finally, the low number of outcomes was a major limitation in our study.

Conclusion

Obesity and physical inactivity are both associated with risk of VTE. Physical activity act as an effect measure modifier of the association between obesity and VTE. Thus, physical activity reduced the absolute rate of VTE among obese individuals, but increased the relative rate of VTE among obese compared with normal weight individuals due to the lower baseline risk of VTE among physically active individuals.